Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Rosiglitazone Autoantibody Positive	15
Overall Study	STARTED	Rosiglitazone Autoantibody Negative	15
Overall Study	STARTED	Glyburide Autoantibody Positive	13
Overall Study	STARTED	Glyburide Autoantibody Negative	21
Overall Study	COMPLETED	Rosiglitazone Autoantibody Positive	4
Overall Study	COMPLETED	Rosiglitazone Autoantibody Negative	10
Overall Study	COMPLETED	Glyburide Autoantibody Positive	7
Overall Study	COMPLETED	Glyburide Autoantibody Negative	9
Overall Study	NOT COMPLETED	Rosiglitazone Autoantibody Positive	11
Overall Study	NOT COMPLETED	Rosiglitazone Autoantibody Negative	5
Overall Study	NOT COMPLETED	Glyburide Autoantibody Positive	6
Overall Study	NOT COMPLETED	Glyburide Autoantibody Negative	12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00194896/flow